Appearance

Following a blood cancer diagnosis, you will have many questions. Some of these may relate to changes to your appearance during cancer treatment.

Some people worry that the appearance-related side effects of treatment will draw attention to the fact that they have cancer, which can affect their self-esteem.

It is important that you are aware of any side effects of your treatment as this can help you to prepare and manage them to give you more control over your body.

Changes to your skin

Your skin may experience changes during blood cancer treatment, but there are ways that you can manage this to reduce discomfort.

Changes to your nails

Some treatments for blood cancer may change the usual look and feel of your nails and can cause discomfort. There are ways to manage this to reduce discomfort and improve the appearance of your nails.

Hair loss

Some blood cancer treatments may cause hair loss on your body. This can be an upsetting time, but there are things you can do to help you cope and feel more in control.

Blood Cancer Awareness Month

Awareness of blood cancers like leukaemia need to be dramatically improved. Help to raise awareness of the signs and symptoms of leukaemia this Blood Cancer Awareness Month and beyond.

Read More

Take a Moment to Catch Up

View our latest news and blog articles

October 31st

October Fundraising: Highlighting our community

With spooky season in full effect, we want to share some of the fang-tastic fundraising you have done this October in support of those living with Leukaemia....

October 20th

Leukaemia Care successfully campaigns for nationwide access to new chronic lymphocytic leukaemia treatment

The National Institute for Health and Care Excellence (NICE) and Scottish Medicines Consortium (SMC) have announced the approval of zanubrutinib on the NHS for patients with chronic lymphocytic leukaemia (CLL) in all nations of the UK....

October 9th

Leukaemia Care successfully campaigns for a new treatment for patients with cytomegalovirus (CMV) in Scotland

Today, the Scottish Medicines Consortium (SMC) has announced the approval of maribavir (Livtencity), a new medicine for adults with a post-transplant CMV infection that is resistant to current treatments. ...